Distribution - In Vitro Tests - Protein Binding-Reference-Cited by-同舟云学术

Distribution - In Vitro Tests - Protein Binding

Published:2013 Issue: Volume: Page:897-913
ISSN:
Container-title:Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
language:
Short-container-title:

Author:

Riedel Jens

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-25240-2_39

Reference60 articles.

1. Barre J, Chamouard JM, Houin G, Tillement JP (1985) Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Clin Chem 31(1):60–64

2. Benet LZ, Hoener B (2002) Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71(3):115–121

3. Blodgett J, Lynch J Millipore™, Application Note AN1733EN00: volume determination methods utilized in drug plasma protein binding (PPB) assays, Millipore, Danvers, MA, USA. http://www.millipore.com

4. Blodgett J, Lynch J Millipore™, Application Note AN1735EN00: evaluation of small molecule non-specific binding, Millipore, Danvers, MA, USA. http://www.millipore.com

5. Boudoulas S, Lush RM, McCall NA, Samid D, Reed E, Figg WD (1996) Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agents. Ther Drug Monit 18:714

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators;RSC Medicinal Chemistry;2021

2. In vitrometabolism of the lignan (−)-grandisin, an anticancer drug candidate, by human liver microsomes;Drug Testing and Analysis;2015-01-15